When BOPA met HOPA: collaborations in oncology pharmacy

When BOPA met HOPA: collaborations in oncology pharmacy

VJHemOnc

1 year
102 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Susannah Koontz Webb, PharmD, BCOP, FHOP, President of the Hematology Oncology Pharmacy Association (HOPA) discusses her session on Collaborative Projects at the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK. The session looked to discuss how organisations like HOPA and BOPA can work together to improve education, guidelines and practises for pharmacists on a global scale in order to optimise cancer care. Dr Koontz Webb describes some of the challenges in oncology pharmacy that could benefit from such partnerships and highlights the important of collaborative approaches. This video has been supported by Napp Pharmaceuticals Ltd through an unrestricted educational grant to Magdalen Medical Publishing.
Up Next Autoplay
Who is Eligible for the AVIATOR Study? @SeattleCCA
Who is Eligible for the AVIATOR Study? @SeattleCCA
Category: Breast Cancer
1 Views
SeattleCCA 1 hour
The AVIATOR Study @SeattleCCA
The AVIATOR Study @SeattleCCA
Category: Breast Cancer
0 Views
SeattleCCA 2 hours
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Category: Liver Cancer
0 Views
imedex 4 hours
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Category: Liver Cancer
0 Views
imedex 4 hours
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Category: Liver Cancer
0 Views
imedex 4 hours
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Category: Liver Cancer
0 Views
imedex 4 hours
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Category: Liver Cancer
0 Views
imedex 4 hours
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Category: Liver Cancer
0 Views
imedex 4 hours
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Category: Liver Cancer
0 Views
imedex 5 hours
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Category: Liver Cancer
0 Views
imedex 5 hours